glp-1 and headaches from Injections Can Semaglutide Cause Headaches? What

And do not chew or crush the tablets

It was approved in the UK in 2023 for weight management in adults with: BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related condition The medication works through several mechanisms: Reduces hunger signals by acting on the brains appetite control centre Slows stomach emptying , creating longer-lasting fullness after meals Reduces food cravings , particularly for ultra-processed foods Improves blood sugar control by enhancing insulin function Clinical trials show that people taking Wegovy lose an average of 15% of their body weight after 68 weeks, compared to 2.4% with placebo

This has been a super positive journey

The GLP-1 receptor is widely distributed in key emotional regulation brain regions such as the limbic system, prefrontal cortex and hypothalamus [30, 31]